Form 8-K - Current report:
SEC Accession No. 0001213900-24-083349
Filing Date
2024-09-30
Accepted
2024-09-30 16:01:16
Documents
15
Period of Report
2024-09-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0216075-8k_incannex.htm   iXBRL 8-K 27891
2 PRESS RELEASE OF INCANNEX HEALTHCARE INC., DATED SEPTEMBER 30, 2024 ea021607501ex99-1_incannex.htm EX-99.1 73344
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3710
  Complete submission text file 0001213900-24-083349.txt   293386

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ixhl-20240930.xsd EX-101.SCH 3024
5 XBRL LABEL FILE ixhl-20240930_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ixhl-20240930_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0216075-8k_incannex_htm.xml XML 3787
Mailing Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008
Business Address 401 DOCKLANDS DRIVE SUITE 15, LEVEL 12 DOCKLANDS, VICTORIA C3 3008 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41106 | Film No.: 241339498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)